Left atrial appendage closure using AMPLATZER™ devices: A large, multicenter, Italian registry

International Journal of Cardiology

21 August Aug 2017 3 months ago
  • Tondo C

Left atrial appendage occlusion (LAAO) has been proven to be effective for stroke prophylaxis in patients with non-valvular atrial fibrillation (NVAF). We aim to assess the safety and efficacy of LAAO by AMPLATZER™ devices in a large, multicenter, single-nation cohort of NVAF patients at high-risk of stroke and bleeding.

Reference
Berti S, Santoro G, Brscic E, Montorfano M, Vignali L, Danna P, Tondo C, D'Amico G, Stabile A, Saccà S, Patti G, Rapacciuolo A, Poli A, Golino P, Magnavacchi P, De Caterina A, Meucci F, Pezzulich B, Rezzaghi M, Stolcova M, Tarantini G. Left atrial appendage closure using AMPLATZER™ devices: A large, multicenter, Italian registry. Int J Cardiol 2017 Jul 16. pii: S0167-5273(17)32822-X. doi: 10.1016/j.ijcard.2017.07.052. [Epub ahead of print]

Go to PubMed